“Now is the time to press our advantage on behalf of patients. Today, we are building upon our success, adding more first- or best-in-class therapies through both internal research and business development. We’ve also stepped back to organize the company around three therapeutic areas with dedicated teams for each program—allowing us to add new programs easily, staff them appropriately, and expand to new areas as compelling opportunities arise. We are now prepared for the expansion phase of Insmed.”